Neumann Diagnostics

NEUMANN is a molecular diagnostics product developer company based in Budapest. The focus of the company is the screening of preventable cancers. It also sells molecular tests to screen for sexually transmitted infections and provides laboratory test platforms with integrated LIS for laboratory service providers. NEUMANN is majority owned by the X-Ventures Beta Venture Capital Fund co-financed by Hungarian private investors and the EIB in the Joint European Resources for Micro to Medium Enterprises (Jeremie) program.